XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income
Treasury Stock
Retained Earnings (Accumulated Deficit)
Beginning balance, common stock (in shares) at Mar. 31, 2024   131,316,309        
Beginning balance at Mar. 31, 2024 $ 1,892,065 $ 131 $ 3,181,366 $ 3,572 $ (1,615,483) $ 322,479
Beginning balance, treasury stock (in shares) at Mar. 31, 2024         59,912,093  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (434,349)          
Unrealized net investment gains 28     28    
Unrealized net (losses) gains on derivative financial instruments 154     154    
Cumulative translation adjustments 397     397    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   2,142,083        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 35,270   35,270      
Issuance of common stock under employee stock purchase plan (in shares)   213,098        
Issuance of common stock under employee stock purchase plan 4,577   4,577      
Repurchase of treasury stock (in shares)         2,044,168  
Repurchase of treasury stock (38,756)       $ (38,756)  
Ending balance, common stock (in shares) at Sep. 30, 2024   133,671,490        
Ending balance at Sep. 30, 2024 1,459,388 $ 133 3,221,213 4,151 $ (1,654,239) (111,870)
Ending balance, treasury stock (in shares) at Sep. 30, 2024         61,956,261  
Beginning balance, common stock (in shares) at Jun. 30, 2024   133,189,228        
Beginning balance at Jun. 30, 2024 1,431,996 $ 133 3,201,998 3,404 $ (1,652,642) (120,897)
Beginning balance, treasury stock (in shares) at Jun. 30, 2024         61,877,819  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 9,027         9,027
Unrealized net investment gains 21     21    
Unrealized net (losses) gains on derivative financial instruments 198     198    
Cumulative translation adjustments 528     528    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   269,164        
Stock-based compensation expense for restricted stock units granted to employees 14,638   14,638      
Issuance of common stock under employee stock purchase plan (in shares)   213,098        
Issuance of common stock under employee stock purchase plan 4,577   4,577      
Repurchase of treasury stock (in shares)         78,442  
Repurchase of treasury stock (1,597)       $ (1,597)  
Ending balance, common stock (in shares) at Sep. 30, 2024   133,671,490        
Ending balance at Sep. 30, 2024 $ 1,459,388 $ 133 3,221,213 4,151 $ (1,654,239) (111,870)
Ending balance, treasury stock (in shares) at Sep. 30, 2024         61,956,261  
Beginning balance, common stock (in shares) at Mar. 31, 2025 72,060,237 134,038,262        
Beginning balance at Mar. 31, 2025 $ 1,560,395 $ 134 3,255,333 4,073 $ (1,654,702) (44,443)
Beginning balance, treasury stock (in shares) at Mar. 31, 2025 61,978,025       61,978,025  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 22,149         22,149
Unrealized net investment gains 13     13    
Unrealized net (losses) gains on derivative financial instruments (128)     (128)    
Cumulative translation adjustments (4)     (4)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   2,069,630        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 32,499   32,499      
Issuance of common stock under employee stock purchase plan (in shares)   216,457        
Issuance of common stock under employee stock purchase plan 5,388   5,388      
Repurchase of treasury stock (in shares)         2,160,272  
Repurchase of treasury stock $ (46,762)       $ (46,762)  
Ending balance, common stock (in shares) at Sep. 30, 2025 72,186,052 136,324,349        
Ending balance at Sep. 30, 2025 $ 1,573,552 $ 136 3,293,220 3,954 $ (1,701,464) (22,294)
Ending balance, treasury stock (in shares) at Sep. 30, 2025 64,138,297       64,138,297  
Beginning balance, common stock (in shares) at Jun. 30, 2025   135,857,091        
Beginning balance at Jun. 30, 2025 $ 1,547,551 $ 135 3,274,682 4,337 $ (1,683,481) (48,122)
Beginning balance, treasury stock (in shares) at Jun. 30, 2025         63,336,389  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 25,828         25,828
Unrealized net investment gains 14     14    
Unrealized net (losses) gains on derivative financial instruments (250)     (250)    
Cumulative translation adjustments (147)     (147)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   250,801        
Issuance of common stock pursuant to vesting of restricted stock units 1 $ 1        
Stock-based compensation expense for restricted stock units granted to employees 13,150   13,150      
Issuance of common stock under employee stock purchase plan (in shares)   216,457        
Issuance of common stock under employee stock purchase plan 5,388   5,388      
Repurchase of treasury stock (in shares)         801,908  
Repurchase of treasury stock $ (17,983)       $ (17,983)  
Ending balance, common stock (in shares) at Sep. 30, 2025 72,186,052 136,324,349        
Ending balance at Sep. 30, 2025 $ 1,573,552 $ 136 $ 3,293,220 $ 3,954 $ (1,701,464) $ (22,294)
Ending balance, treasury stock (in shares) at Sep. 30, 2025 64,138,297       64,138,297